(Q51662333)

9 April 2018

title

Buprenorphine-cocaine interactions in mice: effect on locomotor activity and hole-dipping behaviour. (English)

1 reference

9 April 2018

author name string

Jackson HC

series ordinal

1

1 reference

9 April 2018

Griffin IJ

series ordinal

2

1 reference

9 April 2018

Nutt DJ

series ordinal

3

1 reference

9 April 2018

publication date

1 July 1993

1 reference

9 April 2018

Journal of Pharmacy and Pharmacology

published in

1 reference

9 April 2018

volume

45

1 reference

9 April 2018

issue

7

1 reference

9 April 2018

page(s)

636-640

1 reference

9 April 2018

Monoamine mediation of the morphine-induced activation of mice

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05668.X

Effects of buprenorphine on self-administration of cocaine and a nondrug reinforcer in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05668.X

Agonist and antagonist properties of buprenorphine, a new antinociceptive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05668.X

The animal pharmacology of buprenorphine, an oripavine analgesic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05668.X

Preferential stimulation of dopamine release in the nucleus accumbens by opiates, alcohol, and barbiturates: studies with transcerebral dialysis in freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05668.X

Buprenorphine and temazepam--abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05668.X

Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05668.X

Cocaine conditioned place preference is attenuated by chronic buprenorphine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05668.X

Buprenorphine has potent kappa opioid receptor antagonist activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05668.X

Dopaminergic D-1 receptors: essential role in morphine-induced hypermotility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05668.X

Buprenorphine suppresses heroin use by heroin addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05668.X

Buprenorphine suppresses cocaine self-administration by rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05668.X

Kappa antagonist properties of buprenorphine in the shock titration procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05668.X

Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05668.X

Buprenorphine is an Antagonist at the ϰ Opioid Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05668.X

Antagonism of acute cocaine toxicity by buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05668.X

The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05668.X

The partial opioid agonist, buprenorphine, protects against lethal effects of cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05668.X

10.1111/J.2042-7158.1993.TB05668.X

21 January 2018

Identifiers

DOI

1 reference

9 April 2018

1 reference

9 April 2018